Lexaria Bioscience Corp (LXX.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 10-2013 | 07-2013 | 04-2013 | 01-2013 | 10-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 66 | 28 | 45 | 39 | 181 |
| Receivables | 79 | 152 | 167 | 240 | 291 |
| TOTAL | $146 | $182 | $216 | $285 | $473 |
| Non-Current Assets | |||||
| PPE Net | 3,427 | 3,501 | 3,583 | 3,638 | 3,719 |
| TOTAL | $3,427 | $3,501 | $3,583 | $3,638 | $3,719 |
| Total Assets | $3,573 | $3,683 | $3,799 | $3,923 | $4,192 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,277 | 1,299 | 1,384 | 1,476 | 1,643 |
| Accounts payable and accrued liabilities | 136 | 98 | 92 | 77 | 67 |
| TOTAL | $1,415 | $1,399 | $1,478 | $1,555 | $1,711 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 59 | 59 | 59 | 59 | 59 |
| TOTAL | $59 | $59 | $59 | $59 | $59 |
| Total Liabilities | $1,474 | $1,458 | $1,538 | $1,614 | $1,771 |
| Shareholders' Equity | |||||
| Common Shares | 16 | 16 | 16 | 16 | 16 |
| Retained earnings | -5,058 | -4,931 | -4,874 | -4,826 | -4,714 |
| TOTAL | $2,099 | $2,225 | $2,262 | $2,309 | $2,421 |
| Total Liabilities And Equity | $3,573 | $3,683 | $3,799 | $3,923 | $4,192 |